4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-128431
CIK 0001660719operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 9:37 PM ET
Size
8.8 KB
Accession
0001104659-16-128431
Insider Transaction Report
Form 4
thrasher francis martin
Director
Transactions
- Award
Employee Stock Option (right to buy)
2016-06-16+15,000→ 15,000 totalExercise: $3.42Exp: 2026-06-16→ Common Shares, without par value (15,000 underlying) - Award
Common Shares, without par value
2016-06-16+7,500→ 11,865 total
Holdings
- 272,813(indirect: By 2089636 Ontario Ltd.)
Common Shares, without par value
Footnotes (5)
- [F1]Restricted Stock Units, all of which vest on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.
- [F2]Includes 4,365 shares of Common Stock and 7,500 Restricted Stock Units.
- [F3]Due to a clerical error on the Reporting Person's Form 4, dated as of June 15, 2016, the amount of securities directly beneficially owned by the Reporting Person was incorrectly reported as 277,178 (which reflected the combined amount of securities directly and indirectly owned by the Reporting Person) rather than 4,365. This Form 4 reflects the correct amount of directly beneficially owned securities and indirectly owned securities, properly reported as separate line items.
- [F4]The Reporting Person is the sole owner and president of 2089636 Ontario Ltd.
- [F5]The option vests in one installment on the earlier of June 16, 2017 or the date of the Company's next annual shareholder meeting, subject to the director's continued service on the Board as of such date.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 9:37 PM ET
- Size
- 8.8 KB